Locally advanced breast cancer: Long-term results of a randomized trial comparing primary treatment with tamoxifen or radiotherapy in post-menopausal women

European Journal of Surgical Oncology

Volumn 22, Issue 1, 1996, Pages 34-37

  Willsher, P C ^a   Robertson, J F R ^a   Armitage, N C ^a   Morgan, D A L ^a   Nicholson, R I ^b   Blamey, R W ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^b Tenovus Institute   (United Kingdom)

Author keywords

Radiotherapy; Stage 3 breast cancer; Tamoxifen

Indexed keywords

ANTIESTROGEN; ESTROGEN RECEPTOR; TAMOXIFEN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0029939962     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0748-7983(96)91352-9     Document Type: Article

References (14)

1. Williams MR, Gilson D, Marsh L, et al. The early results from a randomised study of radiotherapy versus Nolvadex (tamoxifen) as initial treatment for stage III breast cancer. Eur J Surg Oncol 1988; 14: 235-40.
2. Hayward JL, Carbone PP, Heuson JC, Kumaoka S, Rubens R. Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland. Cancer 1977; 39: 1289-94.
3. Nicholson RI, Colin P, Francis AB, et al. Evaluation of an enzyme immunoassay for oestrogen receptors in human breast cancers. Cancer Res (Suppl.) 1986; 46: 4299s-4304s.
4. Haagensen CD, Stout AP. Carcinoma of the breast 2: criteria for operability. Ann Surg 1943; 118: 859-70.
5. Spanos WJ, Montague ED, Fletcher GH. Late complications of radiation only for advanced breast cancer. Int J Radiat Biol Phys 1980; 6: 1473-7.
6. Campbell FC, Morgan DAL, Bishop HM, et al. The management of locally advanced carcinoma of the breast by Nolvadex (tamoxifen): a pilot study. Clin Oncol 1984; 10:111-5.
7. Rubens RD, Armitage P, Winter P, et al. Prognosis in inoperable stage 3 carcinoma of the breast. Eur J Cancer 1977; 13: 805-11.
8. Langlands AO, Kerr GR, Shaw S. The management of locally advanced breast cancer by x-ray therapy. Clin Oncol 1976; 2: 365-71.
9. Heys SD, Sarkar K, AH-See AK, et al. Multimodality treatment in the management of locally advanced breast cancer. J Coll Surg Edin 1993; 38: 9-15.
10. Anderson EDC, Forrest APM, Levack U, et al. Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancer. Br J Cancer 1989; 60: 223-6.
11. Robertson JFR, Williams MR, Todd J, Nicholson RI, Morgan DAL, Blamey RW. Factors predicting the response of patients with advanced breast cancer to endocrine (megace) therapy. Eur J Cancer Clin Oncol 1989; 25: 469-75.
12. Howell A, Mackintosh J, Jones M, et al. The definition of the 'no change' category in patients treated with endocrine therapy and chemotherapy for advanced carcinoma of the breast. Eur J Cancer Clin Oncol 1988; 24: 1567-72.
13. Swain SM. Selection of therapy for stage 3 breast cancer. Surg Clin N Am 1990; 70: 1061-80.
14. Rubens RD, Bartelink H, Englesman E, et al. Local advanced breast cancer: the contribution of cytotoxic and endocrine treatment to radiotherapy. Eur J Cancer Clin Oncol 1989; 25: 667-78.